N

Neurostudies, Inc. | Port Charlotte, FL

Research site
(Unclaimed)
Location
4161 Tamiami Trail Suite 201, Port Charlotte, Florida, United States of America

Site insights

Top conditions

Top treatments

Teriflunomide
Ampreloxetine
Remibrutinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

Enrolling
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Remibrutinib

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have particip...

Enrolling
Relapsing Multiple Sclerosis
Biological: 13-valent pneumococcal conjugate vaccine (13-PCV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and sy...

Enrolling
MSA - Multiple System Atrophy
Symptomatic Neurogenic Orthostatic Hypotension
Drug: Ampreloxetine
Drug: Placebo

Trial sponsors

Novartis logo
Theravance Biopharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems